Patent ID: 6897227

Claim:
A compound of Formula 1, Formula 2, Formula 3 or of Formula 4 or isomers of the compounds of Formulas 2 and 3 where the OCH 3 , and HF 2 CO groups, respectively are linked to the 6 position of the benzimidazole ring, and wherein R represents the groups selected from Formulas (i) through (viii); the dashed line represents the bond connecting the R group with the SO 2 group, R 1 and R 2 independently are H, a straight chained or branch-chained di- or trivalant alkyl group of 1 to 12 carbons including 1 or two R 5 groups, or a straight chained or branch-chained saturated hydrocarbon skeleton having no more than 12 carbons including 1 or two R 5 groups and optionally further including one to three X groups where X is independently selected from the group consisting of —O—, —S—, —NR 6 —, —NHCO—, —CONH—, —CONHCO—, —COO—, —OCO— and a disubstituted phenyl group which can optionally be substituted with one or two halogen atoms or with one or two R 3 groups; or the R 5 group is directly attached without an intervening R 1 or R 2 group to the aromatic ring; R 3 and R 4 independently are H, alkyl of 1 to 3 carbons, fluoroalkyl of 1 to 3 carbons, O-alkyl of 1 to 3 carbons, O-fluoroalkyl of 1 to 3 carbons, S-alkyl of 1 to 3 carbons, S-fluoroalkyl of 1 to 3 carbons; R 5 is independently H, COOH or a tetrazole moiety; R 6 is H or alkyl of 1 to 3 carbons; with the provisos that one or more of the R 1 and R 2 groups is not H, and one or more R 5 is not H and no more than two R 5 groups are COOH or tetrazole whereby the compound has one but no more than two COOH or tetrazole groups; or a pharmaceutically acceptable salt of said compound.